• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Jazz Pharmaceuticals

Jazz Pharmaceuticals

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. Jazz Pharmaceuticals Nears Deal to Buy Celator for About $1.5 Billion

    Jazz Pharmaceuticals Nears Deal to Buy Celator for About $1.5 Billion

  2. Correction to Jazz Pharmaceuticals Story

    Correction to Jazz Pharmaceuticals Story

  3. CELATOR PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Sale to Jazz Pharmaceuticals plc

    CELATOR PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Sale to Jazz Pharmaceuticals plc

  4. Cavs-Warriors Game 7 was most-watched NBA game since 1998

    Cavs-Warriors Game 7 was most-watched NBA game since 1998

  5. NBA Finals Game 7 Draws 30.8 Million Viewers

    NBA Finals Game 7 Draws 30.8 Million Viewers

  6. UPDATE: Three reasons why the S&P 500 is primed and ready for some big gains

    UPDATE: Three reasons why the S&P 500 is primed and ready for some big gains

  7. UPDATE: Three reasons why the S&P 500 is primed and ready for big gains

    UPDATE: Three reasons why the S&P 500 is primed and ready for big gains

  8. UPDATE: U.S. stock futures inch higher with action-packed week ahead

    UPDATE: U.S. stock futures inch higher with action-packed week ahead

  9. UPDATE: U.S. stocks edge lower, on track for modest monthly gains

    UPDATE: U.S. stocks edge lower, on track for modest monthly gains

  10. MARKET SNAPSHOT: U.S. Stocks Edge Lower, On Track For Modest Monthly Gains

    MARKET SNAPSHOT: U.S. Stocks Edge Lower, On Track For Modest Monthly Gains

12
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.